Perspective Therapeutics
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Perspective Therapeutics
RECRUITINGPhase 1 / Phase 2NCT06710756
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Phase I/IIa image-guided, alpha-particle therapy study of \[203Pb\]Pb-PSV359 and \[212Pb\]Pb-PSV359 in patients with solid tumors that are known to be Fibroblast Activation...
Sponsor: Perspective TherapeuticsEnrolling: 1123 locations
Pancreatic Ductal AdenocarcinomaGastric CancerEsophageal Cancer+5
RECRUITINGPhase 1 / Phase 2NCT05636618
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors
This study is Phase I/IIa First-in-Human Study of \[212Pb\]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Sponsor: Perspective TherapeuticsEnrolling: 26017 locations
Neuroendocrine Tumors UnresectableNeuroendocrine Tumor MetastaticGastroenteropancreatic Neuroendocrine Tumor+3